Hormone receptor and Her2/neu status pre and post neoadjuvant chemotherapy in breast cancer: Should immunohistochemical studies be repeated?

被引：0
|
作者：
Allison, KA [1 ]
Swanson, PE [1 ]
Lawton, TJ [1 ]
机构：
[1] Univ Washington, Med Ctr, Seattle, WA 98195 USA
来源：
MODERN PATHOLOGY | 2006年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
80
引用
收藏
页码：20A / 20A
页数：1
相关论文
共 50 条
  • [21] The effect of neoadjuvant chemotherapy on histologic grade and hormone receptor status in HER2/Neu-negative Luminal-B tumours of the breast
    Eren, O. C.
    Horoz, S. E.
    Ari, N.
    Menetlioglu, G.
    Kaya, H.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S65 - S66
  • [22] Clinical implication of HER2/neu status in hormone receptor positive pure mucinous breast cancer
    Gwark, S-C
    Lee, J. W.
    Lee, S. B.
    Sohn, G.
    Kim, J.
    Chung, I. Y.
    Ko, B. S.
    Kim, H. J.
    Son, B. H.
    Ahn, S. H.
    CANCER RESEARCH, 2019, 79 (04)
  • [23] Her2 low status and response to neoadjuvant chemotherapy in Her2 negative early breast cancer
    Mattos, Bruna RaphaeliSilva
    Cesca, Marcelle Goldner
    Leite, Luciana de Moura
    Tavares, Monique Celeste
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla AlbinaZanco
    Silva, Erick Figueiredo
    Rocha, Francisca Giselle
    Loose, Simone Klug
    Campos, Fernando AugustoBatista
    Sanches, Solange Moraes
    de Lima, Vladmir ClaudioCordeiro
    Ponde, Noam Falbel
    CANCER RESEARCH, 2021, 81 (04)
  • [24] Is there an association between estrogen receptor and Her2/neu status in breast cancer?
    Hanna, W
    Kahn, HJ
    Szalai, JP
    MODERN PATHOLOGY, 2002, 15 (01) : 36A - 36A
  • [25] Is there an association between estrogen receptor and Her2/neu status in breast cancer?
    Hanna, W
    Kahn, HJ
    Szalai, JP
    LABORATORY INVESTIGATION, 2002, 82 (01) : 36A - 36A
  • [26] Impact of hormone receptor and HER2 conversions on survival after neoadjuvant chemotherapy in breast cancer patients
    Ran Feng
    Lihui Pan
    Yarong Yao
    Jinnan Gao
    Xiaojun Zhang
    Oncology and Translational Medicine, 2025, 11 (02) : 73 - 80
  • [27] Comparison of estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre- and post-neoadjuvant chemotherapy
    Kasami, M.
    Uematsu, T.
    Yabuzaki, T.
    Sugimura, H.
    MODERN PATHOLOGY, 2008, 21 : 41A - 41A
  • [28] Comparison of estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre- and post-neoadjuvant chemotherapy
    Kasami, Masako
    Uematsu, Takayoshi
    Honda, Masatake
    Yabuzaki, Tsugumi
    Sanuki, Junichi
    Uchida, Yoshihiro
    Sugimura, Haruhiko
    BREAST, 2008, 17 (05): : 523 - 527
  • [29] The effect of neoadjuvant chemotherapy on hormone receptor and HER2 profile of primary breast carcinoma
    Xirou, P.
    Vladika, N.
    Barbanis, S.
    Gerasimidou, D.
    Christoforidou, B.
    Iosifidou, R.
    Lalla, E.
    Patakiouta, F.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 265 - 265
  • [30] Neoadjuvant chemotherapy with HER2 inhibitors for breast cancer
    Fujita, Tetsuji
    LANCET, 2012, 379 (9833): : 2237 - 2237
12345